Raymond James Financial’s Trevi Therapeutics TRVI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$5.89M Buy
1,076,683
+567,304
+111% +$3.1M ﹤0.01% 2262
2025
Q1
$3.2M Buy
509,379
+497,379
+4,145% +$3.13M ﹤0.01% 2649
2024
Q4
$49.4K Buy
+12,000
New +$49.4K ﹤0.01% 4560